Figure 5.

Correlation between the dose of NK1 cells infused and chronic GVHD. A shows the comparison of the dose of NK1 cells infused in allografts among patients without chronic GVHD (n = 21), with chronic GVHD (18) or with extensive chronic GVHD (n = 10); the estimated cumulative incidence rates of overall chronic GVHD (B) and extensive chronic GVHD (C) for patients in the low and high NK1 cell groups are separated according to the cut‐off number of NK1 cells in the allograft (4.8 × 10⁶/kg). The data shown are pooled from 41 experiments